These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 18158341
1. Osteopontin in rat renal fibroblasts: functional properties and transcriptional regulation by aldosterone. Irita J, Okura T, Kurata M, Miyoshi K, Fukuoka T, Higaki J. Hypertension; 2008 Feb; 51(2):507-13. PubMed ID: 18158341 [Abstract] [Full Text] [Related]
2. Synergistic induction of osteopontin by aldosterone and inflammatory cytokines in mesangial cells. Gauer S, Hauser IA, Obermüller N, Holzmann Y, Geiger H, Goppelt-Struebe M. J Cell Biochem; 2008 Feb 01; 103(2):615-23. PubMed ID: 17546625 [Abstract] [Full Text] [Related]
3. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Renault MA, Jalvy S, Belloc I, Pasquet S, Sena S, Olive M, Desgranges C, Gadeau AP. Circ Res; 2003 Oct 03; 93(7):674-81. PubMed ID: 12970113 [Abstract] [Full Text] [Related]
4. Aldosterone-induced osteopontin gene transcription in vascular smooth muscle cells involves glucocorticoid response element. Kiyosue A, Nagata D, Myojo M, Sato T, Takahashi M, Satonaka H, Nagai R, Hirata Y. Hypertens Res; 2011 Dec 03; 34(12):1283-7. PubMed ID: 21814207 [Abstract] [Full Text] [Related]
5. NF-κB- and AP-1-mediated DNA looping regulates osteopontin transcription in endotoxin-stimulated murine macrophages. Zhao W, Wang L, Zhang M, Wang P, Zhang L, Yuan C, Qi J, Qiao Y, Kuo PC, Gao C. J Immunol; 2011 Mar 01; 186(5):3173-9. PubMed ID: 21257959 [Abstract] [Full Text] [Related]
6. Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration in aldosterone-induced hypertension. Tostes RC, Touyz RM, He G, Chen X, Schiffrin EL. Clin Sci (Lond); 2002 Aug 01; 103 Suppl 48():25S-30S. PubMed ID: 12193048 [Abstract] [Full Text] [Related]
7. CREB mediates UTP-directed arterial smooth muscle cell migration and expression of the chemotactic protein osteopontin via its interaction with activator protein-1 sites. Jalvy S, Renault MA, Lam Shang Leen L, Belloc I, Reynaud A, Gadeau AP, Desgranges C. Circ Res; 2007 May 11; 100(9):1292-9. PubMed ID: 17413042 [Abstract] [Full Text] [Related]
8. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Ogawa D, Stone JF, Takata Y, Blaschke F, Chu VH, Towler DA, Law RE, Hsueh WA, Bruemmer D. Circ Res; 2005 Apr 15; 96(7):e59-67. PubMed ID: 15790955 [Abstract] [Full Text] [Related]
9. UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. Renault MA, Jalvy S, Potier M, Belloc I, Genot E, Dekker LV, Desgranges C, Gadeau AP. J Biol Chem; 2005 Jan 28; 280(4):2708-13. PubMed ID: 15557322 [Abstract] [Full Text] [Related]
10. Adiponectin induces interleukin-6 production and its underlying mechanism in adult rat cardiac fibroblasts. Fan D, Li L, Wang C, Cui XB, Zhou Y, Wu LL. J Cell Physiol; 2011 Jul 28; 226(7):1793-802. PubMed ID: 21069809 [Abstract] [Full Text] [Related]
11. Oxidative stress enhances AP-1 and NF-κB-mediated regulation of β(2)-glycoprotein I gene expression in hepatoma cells. Chiu WC, Chen CJ, Lee TS, Chen ZJ, Ke PH, Chiang AN. J Cell Biochem; 2010 Nov 01; 111(4):988-98. PubMed ID: 20665665 [Abstract] [Full Text] [Related]
12. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A. Hypertension; 2005 Oct 01; 46(4):1039-45. PubMed ID: 16087786 [Abstract] [Full Text] [Related]
13. Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells. Ahmed M, Kundu GC. Mol Cancer; 2010 May 07; 9():101. PubMed ID: 20459645 [Abstract] [Full Text] [Related]
14. Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis. Matthews CP, Birkholz AM, Baker AR, Perella CM, Beck GR, Young MR, Colburn NH. Cancer Res; 2007 Mar 15; 67(6):2430-8. PubMed ID: 17363560 [Abstract] [Full Text] [Related]
15. Osteopontin Promotes Oncostatin M Production in Human Osteoblasts: Implication of Rheumatoid Arthritis Therapy. Su CM, Chiang YC, Huang CY, Hsu CJ, Fong YC, Tang CH. J Immunol; 2015 Oct 01; 195(7):3355-64. PubMed ID: 26304992 [Abstract] [Full Text] [Related]
16. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Samant RS, Clark DW, Fillmore RA, Cicek M, Metge BJ, Chandramouli KH, Chambers AF, Casey G, Welch DR, Shevde LA. Mol Cancer; 2007 Jan 16; 6():6. PubMed ID: 17227585 [Abstract] [Full Text] [Related]
17. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor. Schultz J, Lorenz P, Ibrahim SM, Kundt G, Gross G, Kunz M. Mol Carcinog; 2009 Jan 16; 48(1):14-23. PubMed ID: 18459127 [Abstract] [Full Text] [Related]
18. CysLT1 receptor engagement induces activator protein-1- and NF-kappaB-dependent IL-8 expression. Thompson C, Cloutier A, Bossé Y, Thivierge M, Gouill CL, Larivée P, McDonald PP, Stankova J, Rola-Pleszczynski M. Am J Respir Cell Mol Biol; 2006 Dec 16; 35(6):697-704. PubMed ID: 16809637 [Abstract] [Full Text] [Related]
19. Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms. Chen D, Chen Z, Park C, Centrella M, McCarthy T, Chen L, Al-Omari A, Moeckel GW. Gene; 2013 Nov 15; 531(1):23-30. PubMed ID: 23994292 [Abstract] [Full Text] [Related]
20. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney. Irita J, Okura T, Jotoku M, Nagao T, Enomoto D, Kurata M, Desilva VR, Miyoshi K, Matsui Y, Uede T, Denhardt DT, Rittiling SR, Higaki J. Am J Physiol Renal Physiol; 2011 Oct 15; 301(4):F833-44. PubMed ID: 21734100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]